General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash and cash equivalents    
Cash and cash equivalents at end of period $ 1,328,000  
Evolv Technologies Holdings, Inc.    
Cash flows from operating activities:    
Net loss (27,392,000) $ (19,857,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 1,065,000 535,000
Stock-based compensation 662,000 264,000
Noncash interest expense 25,000 498,000
Loss on extinguishment of debt 66,000 679,000
Provision recorded for allowance for doubtful accounts 47,000 16,000
Provision recorded for warranty accrual (14,000) 55,000
Changes in operating assets and liabilities    
Accounts receivable (464,000) (706,000)
Inventory (1,471,000) 229,000
Commission assets (1,785,000) (507,000)
Prepaid expenses and other current assets (375,000) 1,259,000
Accounts payable 1,915,000 (144,000)
Deferred revenue 2,341,000 1,372,000
Deferred rent (34,000) (26,000)
Accrued expenses and other current liabilities 2,160,000 1,155,000
Net cash used in operating activities (23,254,000) (15,178,000)
Cash flows from investing activities:    
Purchases of property and equipment (6,609,000) (731,000)
Net cash used in investing activities (6,609,000) (731,000)
Cash flows from financing activities:    
Proceeds from issuance of Series B-1 convertible preferred stock, net of issuance costs 2,994,000 22,366,000
Proceeds from exercise of stock options 442,000 28,000
Proceeds from financing obligations   723,000
Proceeds from long-term debt, net of issuance costs 22,438,000 5,497,000
Repayment of financing obligations (244,000) (120,000)
Repayment of principal on long-term debt (8,404,000) (706,000)
Net cash provided by financing activities 17,226,000 27,788,000
Net increase (decrease) in cash and cash equivalents (12,637,000) 11,879,000
Cash and cash equivalents    
Cash and cash equivalents at beginning of period 17,341,000 5,462,000
Cash and cash equivalents at end of period 4,704,000 17,341,000
Supplemental disclosure of cash flow information    
Cash paid for interest 405,000 281,000
Cash paid for income taxes   2,000
Supplemental disclosure of non-cash activities    
Issuance of Series B1 convertible preferred stock for the conversion of convertible notes   6,595,000
Issuance of equity classified warrants 112,000 3,000
Transfers of inventory to property and equipment 86,000 $ 1,879,000
Issuance of a nonrecourse promissory note with officer $ 350,000